Accelerate Diagnostics
AXDX
#10563
Rank
HK$6.69 M
Marketcap
HK$0.26
Share price
0.00%
Change (1 day)
-98.00%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : HK$0.65 Billion

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are HK$0.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.40 B-41.3%
2022-12-31HK$0.68 B-25.96%
2021-12-31HK$0.92 B-23.96%
2020-12-31HK$1.21 B9.67%
2019-12-31HK$1.10 B10.27%
2018-12-31HK$1.00 B1782.84%
2017-12-31HK$53.19 M36.2%
2016-12-31HK$39.05 M-20.1%
2015-12-31HK$48.87 M65.39%
2014-12-31HK$29.55 M99.11%
2013-12-31HK$14.84 M
2012-07-31HK$18.43 M63.3%
2011-07-31HK$11.29 M6.95%
2010-07-31HK$10.55 M1.89%
2009-07-31HK$10.36 M-6.13%
2008-07-31HK$11.03 M12.1%
2007-07-31HK$9.84 M14.25%
2006-07-31HK$8.61 M-17.23%
2005-07-31HK$10.41 M35.1%
2004-07-31HK$7.7 M-2.75%
2003-07-31HK$7.92 M-20.57%
2002-07-31HK$9.97 M14.19%
2001-07-31HK$8.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
HK$403.77 B 61,210.23%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$51.41 B 7,706.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$229.10 B 34,687.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$23.04 B 3,398.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
HK$2.53 B 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
HK$30.69 B 4,560.39%๐Ÿ‡บ๐Ÿ‡ธ USA